<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01067677</url>
  </required_header>
  <id_info>
    <org_study_id>1-Cladis</org_study_id>
    <nct_id>NCT01067677</nct_id>
  </id_info>
  <brief_title>Rescue Emetic Therapy for Children Having Elective Surgery</brief_title>
  <acronym>RETCHES</acronym>
  <official_title>Rescue Emetic Therapy for Children Having Elective Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Franklyn Cladis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare ondansetron, metoclopramide, diphenhydramine, and placebo in order to determine
      which anti-emetic is most efficacious as a &quot;rescue therapy&quot; for pediatric patients ages 3-18
      who have post-operative vomiting after a standardized prophylactic regimen of ondansetron and
      dexamethasone. We hypothesize that anti-emetics with a different mechanism of action than the
      prophylactic regimen will be the most effective &quot;rescue therapy&quot; in children having surgery
      in an ambulatory surgery center.

        1. Problem: Despite commonly-used anti-emetics for prophylaxis, some children still go on
           to develop post-operative vomiting (POV).

           Goal: To determine which anti-emetic--ondansetron, metoclopramide, diphenhydramine, or
           placebo--is most efficacious for pediatric patients in this situation.

        2. Hypothesis: Anti-emetic medications that have a different mechanism of action than the
           prophylactic regimen will be the most efficacious &quot;rescue therapy.&quot;

        3. Hypothesis: Metoclopramide at the dose of 0.5 mg/kg (max dose 20 mg) will be more
           effective than ondansetron, diphenhydramine, or placebo as &quot;rescue therapy.&quot;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    We do not have the funding or resources to complete the study at this time
  </why_stopped>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary-Incidence of POV after rescue antiemetic in PACU, car ride home, day of surgery, and POD #1 and 2</measure>
    <time_frame>48 hrs</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary - a. Discharge times</measure>
    <time_frame>48 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events (headaches, sedation, dystonic reaction, dry mouth)</measure>
    <time_frame>48 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POV risk factors. age, personal or family history of PONV, history of motion sickness, personal or family history of smoking</measure>
    <time_frame>48 hrs</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Post Operative Nausea and Vomiting</condition>
  <condition>Rescue Emetic Therapy</condition>
  <arm_group>
    <arm_group_label>Metoclopramide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rescue emetic therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ondansetron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rescue emetic therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diphenhydramine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rescue emetic therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metaclopramide</intervention_name>
    <description>0.5 mg/kg for rescue after PONV</description>
    <arm_group_label>Metoclopramide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron</intervention_name>
    <description>0.1 mg/kg (max 4 mg0</description>
    <arm_group_label>Ondansetron</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diphenhydramine</intervention_name>
    <description>0.25 mg/kg (max 25 mg)</description>
    <arm_group_label>Diphenhydramine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>equal volume (5 ml)as experimental rescue medications</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Pediatric patients 3-17 years old

          2. Patients scheduled for tonsillectomy and/or adenoidectomy (with and without
             myringotomy) , or dental restoration,

          3. Patients receiving a general anesthetic (inhaled agent without nitrous oxide) with POV
             prophylaxis with two agents (ondansetron and dexamethasone)

          4. Post operative vomiting in PACU or second stage recovery requiring antiemetic rescue.

        Exclusion Criteria:

          1. Vomiting in the past 24 hours or antiemetics in previous 24 hours

          2. Allergy or sensitivity to ondansetron, dexamethasone, metoclopramide, or
             diphenhydramine

          3. Patients with diabetes

          4. Patients with seizures

          5. Patients receiving a benzodiazepine premedication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franklyn P Cladis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2010</study_first_submitted>
  <study_first_submitted_qc>February 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2010</study_first_posted>
  <last_update_submitted>November 12, 2017</last_update_submitted>
  <last_update_submitted_qc>November 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Franklyn Cladis</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>PONV</keyword>
  <keyword>Post operative nausea and vomiting</keyword>
  <keyword>rescue emetic therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Diphenhydramine</mesh_term>
    <mesh_term>Metoclopramide</mesh_term>
    <mesh_term>Promethazine</mesh_term>
    <mesh_term>Emetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

